252
Participants
Start Date
July 31, 2011
Primary Completion Date
November 30, 2013
Study Completion Date
December 31, 2013
Aripiprazole
Aripiprazole (2-mg, 5-mg, 10-mg, 15-mg, 20-mg, 25-mg or 30-mg)
Aripiprazole
Aripiprazole (10-mg, 15-mg, 20-mg, 25-mg or 30-mg)
Study Site, Taipei
Study Site, Taoyuan
Study Site, Kaohsiung County
Study Site, Manila
Study Site, Mandaluyong
Study Site, Dasmariñas
Study Site, Iloilo City
Study Site, Bajada
Study Site, Chapel Hill
Study Site, Atlanta
Study Site, Ipoh
Study Site, Miami
Study Site, Miami Springs
Study Site, Bloomfield Hills
Study Site, Kuala Lumpur
Study Site, Batu Caves
Study Site, Johor Bahru
Study Site, Downy
Study Site, Glendale
Study Site, Bothell
Study Site, Moscow
Study Site, Moscow
Study Site, Yaroslavl
Study Site, Arkhangelsk
Study Site, Petrozavodsk
Study Site, Saint Petersburg
Study Site, Saint Petersburg
Study Site, Craiova
Study Site, Varanasi
Study Site, Lucknow
Study Site, Timișoara
Study Site, Tonnelnyi Township
Study Site, Maninagar, Ahmedabad
Study Site, Lipetsk
Study Site, Cluj-Napoca
Study Site, Saratov
Study Site, Kazan'
Study Site, Aurangabad
Study Site, Wardha
Study Site, Orenburg
Study Site, Raipur
Study Site, Vijayawada
Study Site, Guntur
Study Site, Visakhapatnam
Study Site, Chennai
Study Site, Nizhny Novgorod
Study Site, Yekaterinburg
Study Site, Madurai
Study Site, Novosibirsk
Study Site, Tomsk
Study Site, Iași
Study Site, Bucharest
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY